Comprehensive analytical characterization of the proposed biosimilar trastuzumab (Record no. 17361)

000 -LEADER
fixed length control field a
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220829162433.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220829b xxu||||| |||| 00| 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency AIKTC-KRRC
Transcribing agency AIKTC-KRRC
100 ## - MAIN ENTRY--PERSONAL NAME
9 (RLIN) 17659
Author Dakshinamurthy, Pravin Kumar
245 ## - TITLE STATEMENT
Title Comprehensive analytical characterization of the proposed biosimilar trastuzumab
250 ## - EDITION STATEMENT
Volume, Issue number Vol.56(2), Apr-June
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Karnataka
Name of publisher, distributor, etc. Association of Pharmaceutical Teachers of India (APTI)
Year 2022
300 ## - PHYSICAL DESCRIPTION
Pagination 438-447p.
520 ## - SUMMARY, ETC.
Summary, etc. Background: Biosimilars to monoclonal antibodies were developed to increase the
accessibility of this drug and reduce the costs of this therapy without compromising on its
quality, safety, and efficacy. The objective of this research is to describe the orthogonal
analytical methods used for the physicochemical and biological characterization of the
biosimilar proposed to trastuzumab, which is the basis of the biosimilar development
program. Methods: The orthogonal analytical methods for characterization of the
proposed biosimilar to trastuzumab were segregated based on the quality attributes
of the product, such as the primary structure was evaluated using peptide mapping
and high-end mass spectrometry, secondary and tertiary structure was evaluated
using circular dichroism, fluorescence, and absorbance spectroscopy, identity and size
heterogeneity were evaluated using Western blotting, size exclusion chromatography and
capillary electrophoresis, charge heterogeneity, glycan heterogeneity and hydrophobic
heterogeneity were evaluated using by weak cation exchange liquid chromatography,
hydrophilic interaction chromatography and reverse phase liquid chromatography, antigen
binding and Fc gamma receptor binding was evaluated using surface plasmon resonance,
flow cytometry and cell-based enzyme linked immunosorbent assay, antiproliferation and
antibody dependent cellular cytotoxicity were evaluated using
in vitro cell-based bioassay.
Results and Conclusion: The results of a comprehensive analytical characterization of
the proposed biosimilar to the innovator trastuzumab confirm that the physicochemical
and biological properties of the proposed biosimilar were comparable to those of the
innovator molecule trastuzumab.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
9 (RLIN) 4639
Topical term or geographic name entry element PHARMACEUTICS
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 17660
Co-Author Gothandam, Kodiveri Muthukaliannan
773 0# - HOST ITEM ENTRY
Place, publisher, and date of publication Bengluru Association of Pharmaceutical Teachers of India (APTI)
International Standard Serial Number 0019-5464
Title Indian journal of pharmaceutical education and research
856 ## - ELECTRONIC LOCATION AND ACCESS
URL https://www.ijper.org/sites/default/files/IndJPhaEdRes-56-2-438.pdf
Link text Click here
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Articles Abstract Database
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Permanent Location Current Location Shelving location Date acquired Barcode Date last seen Price effective from Koha item type
          School of Pharmacy School of Pharmacy Archieval Section 2022-08-29 2022-1428 2022-08-29 2022-08-29 Articles Abstract Database
Unique Visitors hit counter Total Page Views free counter
Implemented and Maintained by AIKTC-KRRC (Central Library).
For any Suggestions/Query Contact to library or Email: librarian@aiktc.ac.in | Ph:+91 22 27481247
Website/OPAC best viewed in Mozilla Browser in 1366X768 Resolution.

Powered by Koha